COVID-19 pandemic in Nigeria

COVID-19 pandemic in Nigeria
Name	COVID-19 pandemic in Nigeria
Disease	COVID-19
Virus strain	SARS-CoV-2
Location	Nigeria
First case	Lagos State
Arrival date	2020

COVID-19 pandemic in Nigeria began when SARS-CoV-2 cases were detected in Nigeria, prompting responses across Lagos State, Abuja, Kaduna State, Rivers State, and other subnational entities. The outbreak influenced institutions such as the Nigerian Centre for Disease Control, World Health Organization, African Union, National Assembly (Nigeria), and affected sectors linked to Shell plc, Dangote Group, Nigerian National Petroleum Corporation, Central Bank of Nigeria, and Nigerian National Petroleum Corporation Limited. International actors including United Nations, European Union, Bill & Melinda Gates Foundation, World Bank, and International Monetary Fund engaged with Nigeria on health financing and logistics.

Background

Nigeria, a federation composed of Lagos State, Kano State, Rivers State, and 34 other states, maintains public health infrastructure featuring the Nigerian Centre for Disease Control, university hospitals such as University of Ibadan, University of Nigeria Teaching Hospital, and research institutes like African Centre of Excellence for Genomics of Infectious Diseases and Redeemer's University. Nigeria's prior experience with outbreaks—including the 2014 Ebola virus epidemic in West Africa and recurring Lassa fever outbreaks—shaped preparedness alongside partnerships with the World Health Organization African Region, African Union Development Agency, Médecins Sans Frontières, and regional bodies like Economic Community of West African States. Nigeria's transport hubs including Murtala Muhammed International Airport, Nnamdi Azikiwe International Airport, and seaports handled early screening and containment challenges.

Timeline

The first confirmed case involved an individual returning via Murtala Muhammed International Airport to Lagos State from Milano Malpensa Airport-linked travel, with subsequent events attracting attention from figures such as Babatunde Fashola and Sani Abacha-era institutions. Rapid case increases occurred in metropolitan centers like Lagos, Abuja, Kano, and Port Harcourt. Key milestones included implementation of lockdowns guided by directives from Muhammadu Buhari, policy coordination by the Presidential Task Force on COVID-19 (Nigeria), testing scale-up at laboratories including National Reference Laboratory, Abuja, and involvement of scientists linked to University of Lagos and Ahmadu Bello University. Waves corresponded with global surges tracked alongside Alpha variant, Delta variant, and Omicron variant observations noted by genomic surveillance initiatives.

Government response and public health measures

Authorities activated emergency mechanisms involving the Presidential Task Force on COVID-19 (Nigeria), state governors such as Babajide Sanwo-Olu and Aminu Bello Masari, and agencies including the Nigeria Centre for Disease Control and Federal Ministry of Health (Nigeria). Measures included movement restrictions affecting Lagos State, closure of religious sites like National Mosque, Abuja and National Christian Centre, school suspensions impacting institutions such as University of Ibadan and Ahmadu Bello University, and travel bans coordinated with Federal Airports Authority of Nigeria. Public communications involved figures like Osagie Ehanire and deployments of emergency funding from the Central Bank of Nigeria and assistance from World Bank programmes. Legal and legislative dimensions engaged the National Assembly (Nigeria) and state judiciaries in disputes over lockdown orders.

Healthcare system impact and capacity

Hospitals including University College Hospital, Ibadan, Lagos University Teaching Hospital, and Ahmadu Bello University Teaching Hospital faced strain on intensive care resources, oxygen supply chains, and personal protective equipment procurement involving suppliers linked to Seplat Energy logistics. Healthcare workforce issues affected professionals affiliated with Nigerian Medical Association, nursing associations, and community health workers trained via programmes with UNICEF and USAID. Laboratory expansion leveraged networks such as the African Centre of Excellence for Genomics of Infectious Diseases and collaborations with Public Health England-linked laboratories, while referral systems incorporated state tertiary centres and private facilities like Reddington Hospital.

Economic and social effects

Economic disruptions affected sectors led by Dangote Group, Nigerian National Petroleum Corporation, Guaranty Trust Bank, and the Nigerian Stock Exchange (NGX), prompting fiscal responses by the Central Bank of Nigeria and budgetary adjustments by the Federal Ministry of Finance (Nigeria). Social consequences influenced markets in Balogun Market, schooling at institutions like University of Lagos, and livelihoods of transport workers associated with unions such as the Trade Union Congress of Nigeria and Nigeria Labour Congress. Humanitarian and food security concerns engaged World Food Programme, Oxfam, and local NGOs responding in states including Borno State and Katsina State.

Vaccination rollout

Vaccination campaigns used supplies including Oxford–AstraZeneca COVID-19 vaccine, Pfizer–BioNTech COVID-19 vaccine, and donations via COVAX involving partnerships with UNICEF and Gavi, the Vaccine Alliance. Rollout prioritized health workers registered with the Nigeria Medical Association, elderly populations, and frontline staff in urban centres like Lagos and Abuja. Cold-chain logistics relied on infrastructure in ports such as Apapa Port, national warehouses, and coordination with agencies like the National Primary Health Care Development Agency. Public uptake intersected with outreach through religious leaders from Nigerian Christian Association of Churches and Supreme Council for Islamic Affairs.

Data, surveillance, and variants

Epidemiological monitoring by the Nigerian Centre for Disease Control and genomic sequencing by institutions like the African Centre of Excellence for Genomics of Infectious Diseases and university laboratories tracked case counts, test positivity, and emergence of lineages including Alpha variant, Delta variant, and Omicron variant. International reporting aligned with databases maintained by the World Health Organization, Africa Centres for Disease Control and Prevention, and research consortia such as the COVID-19 Genomics UK (COG-UK) Consortium collaborations. Surveillance utilized sentinel sites in states like Kano State and genomic data informed policy decisions by the Presidential Task Force on COVID-19 (Nigeria) and public health officials.

Category:Health in Nigeria